A postage-stamp chip captures the 10-week clock of a developing human heart valve

Human heart valves take nearly 10 weeks to develop in ways zebrafish and mouse hearts do not, and animal stand-ins do not capture that biology. A Cell Stem Cell paper00271-7) from a University of Pittsburgh and Carnegie Mellon team reports the first platform that can: a postage-stamp-sized microfluidic chip lined with iPSC-derived heart tissue (an adult cell reprogrammed back into a stem cell, then coaxed into heart lineages) and a valve that forms on the assembloid's surface, where "assembloid" means organoids of distinct cell types combined to mimic a more complex organ.

The chip pumps flowing medium to mimic blood and feeds endothelial cells to mimic the lining of real valves, reproducing the hemodynamic load a developing human valve actually endures, according to the University of Pittsburgh release.

The team frames the work as a model, not a treatment. Animal hearts remain the default for now, and clinical translation is years away. The platform's immediate value is a chance to watch congenital and acquired human valve disease, including calcification and fibrotic remodeling, unfold in a dish, in days, and from a patient's own cells, according to the team's coverage and independent re-reports.

Medical Xpress also covered the publication.